StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Vaccinex's shares outstanding was 3M at Dec 31, 2024. For fiscal 2024 it was 2M, up 352.7% from the year before. The highest annual figure on record is 2M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2024Dec 31, 20242M+352.7%
FY2023Dec 31, 20230M+129.4%
FY2022Dec 31, 20220M+47.1%
FY2021Dec 31, 20210M+53.6%
FY2020Dec 31, 20200M+45.9%
FY2019Dec 31, 20190M+146.6%
FY2018Dec 31, 20180M+374.1%
FY2017Dec 31, 20170M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 20243M+900.6%
Q3 FY2024Sep 30, 20242M+604.5%
Q2 FY2024Jun 30, 20242M+665.2%
Q1 FY2024Mar 31, 20241M+510.4%
Q3 FY2023Sep 30, 20230M+58.6%
Q2 FY2023Jun 30, 20230M+41.6%
Q1 FY2023Mar 31, 20230M+28.7%
Q4 FY2022Dec 31, 20220M+48.2%
Q3 FY2022Sep 30, 20220M+38.5%
Q2 FY2022Jun 30, 20220M+49.3%
Q1 FY2022Mar 31, 20220M+53.7%
Q4 FY2021Dec 31, 20210M+37.6%
Q3 FY2021Sep 30, 20210M+53.4%
Q2 FY2021Jun 30, 20210M+71.2%
Q1 FY2021Mar 31, 20210M+57.6%
Q4 FY2020Dec 31, 20200M+51.4%
Q3 FY2020Sep 30, 20200M+45.9%
Q2 FY2020Jun 30, 20200M+45.4%
Q1 FY2020Mar 31, 20200M+39.4%
Q4 FY2019Dec 31, 20190M+108.8%
Q3 FY2019Sep 30, 20190M+1147.3%
Q2 FY2019Jun 30, 20190M+941.2%
Q1 FY2019Mar 31, 20190M+940.9%
Q3 FY2018Sep 30, 20180M+542.1%
Q2 FY2018Jun 30, 20180M+0.1%
Q1 FY2018Mar 31, 20180M–
Q4 FY2017Dec 31, 20170M–
Q3 FY2017Sep 30, 20170M–
Q2 FY2017Jun 30, 20170M–

More Vaccinex figures

See a number that looks wrong?